Qsemble Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,122
Closed -$2.49M 459
2025
Q4
$2.49M Buy
12,122
+6,945
+134% +$1.31M 0.21% 160
2025
Q3
$813K Sell
5,177
-26,559
-84% -$4.1M 0.08% 269
2025
Q2
$5.33M Buy
31,736
+26,463
+502% +$3.93M 0.51% 63
2025
Q1
$726K Buy
+5,273
New +$672K 0.08% 258
2024
Q4
Sell
-11,698
Closed -$1.29M 396
2024
Q3
$1.29M Buy
+11,698
New +$1.22M 0.24% 139
2024
Q2
Sell
-6,207
Closed -$695K 439
2024
Q1
$695K Sell
6,207
-6,111
-50% -$659K 0.15% 222
2023
Q4
$1.24M Sell
12,318
-13,382
-52% -$1.33M 0.31% 112
2023
Q3
$2.23M Buy
25,700
+19,100
+289% +$1.73M 0.42% 84
2023
Q2
$624K Buy
+6,600
New +$557K 0.44% 94

Other funds holding CAH

Qsemble Capital Management's CAH Position: Q1 2026 in Review

Qsemble Capital Management sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 12,122 shares — an estimated $2.49M sold.

Qsemble Capital Management first reported a position in CAH in Q2 2023 and held it in 9 quarters. The position peaked at $5.33M in Q2 2025. 1,433 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Qsemble Capital Management reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Qsemble Capital Management sold 12,122 Cardinal Health shares in Q1 2026, an estimated $2.49M.
  • Qsemble Capital Management first reported a position in Cardinal Health in Q2 2023 and held it in 9 quarters.
  • Qsemble Capital Management's Cardinal Health position peaked at $5.33M in Q2 2025.
  • 1,433 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Qsemble Capital Management's 13F filing for Q1 2026, filed 7 May 2026.